Related Experiment Video
Updated: Oct 12, 2025

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP
Published on: January 24, 2025
Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells
Patrick J Flynn1, Peter D Koch2, Timothy J Mitchison1
1Department of Systems Biology, Harvard Medical School, Boston, MA 02115; patrick_flynn@hms.harvard.edu timothy_mitchison@hms.harvard.edu.
Abstract:
Mitotic errors can activate cyclic GMP-AMP synthase (cGAS) and induce type I interferon (IFN) signaling. Current models propose that chromosome segregation errors generate micronuclei whose rupture activates cGAS. We used a panel of antimitotic drugs to perturb mitosis in human fibroblasts and measured abnormal nuclear morphologies, cGAS localization, and IFN signaling in the subsequent interphase. Micronuclei consistently recruited cGAS without activating it. Instead, IFN signaling correlated with formation of cGAS-coated chromatin bridges that were selectively generated by microtubule stabilizers and MPS1 inhibitors. cGAS activation by chromatin bridges was suppressed by drugs that prevented cytokinesis. We confirmed cGAS activation by chromatin bridges in cancer lines that are unable to secrete IFN by measuring paracrine transfer of 2'3'-cGAMP to fibroblasts, and in mouse cells. We propose that cGAS is selectively activated by self-chromatin when it is stretched in chromatin bridges. Immunosurveillance of cells that fail mitosis, and antitumor actions of taxanes and MPS1 inhibitors, may depend on this effect.
Insights
Mitotic errors activate cyclic GMP-AMP synthase (cGAS) by stretching chromatin bridges, not micronuclei, inducing type I interferon (IFN) signaling. This finding reveals a new mechanism for immune surveillance and potential anti-cancer drug targets.
Area of Science:
- Cell Biology
- Immunology
- Molecular Biology
Background:
- Mitotic errors can trigger innate immune responses via cyclic GMP-AMP synthase (cGAS) and type I interferon (IFN) signaling.
- Existing models suggest micronuclei rupture activates cGAS following chromosome segregation errors.
Purpose of the Study:
- To investigate the precise mechanism of cGAS activation during mitotic errors.
- To determine the role of abnormal nuclear morphologies in cGAS activation and IFN signaling.
Main Methods:
- Human fibroblasts were treated with antimitotic drugs to induce mitotic errors.
- Abnormal nuclear morphologies, cGAS localization, and IFN signaling were measured.
- cGAS activation was assessed in cancer cell lines and mouse cells.
Main Results:
- Micronuclei recruited cGAS but did not activate it.
- Interferon signaling correlated with cGAS-coated chromatin bridges, particularly those induced by microtubule stabilizers and MPS1 inhibitors.
- cGAS activation by chromatin bridges was dependent on cytokinesis and occurred when chromatin was stretched.
Conclusions:
- cGAS is activated by stretched chromatin bridges during failed mitosis, not by micronuclei.
- This mechanism contributes to immune surveillance of mitotic errors and may underlie the antitumor effects of certain drugs.
- Targeting cGAS activation by chromatin bridges could offer new therapeutic strategies.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Inheritance of Chromatin Structures
Mitogens and the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Crossing Over

